• LAST PRICE
    5.8300
  • TODAY'S CHANGE (%)
    Trending Down-0.0200 (-0.3419%)
  • Bid / Lots
    5.8100/ 5
  • Ask / Lots
    5.8500/ 2
  • Open / Previous Close
    5.9250 / 5.8500
  • Day Range
    Low 5.6000
    High 5.9250
  • 52 Week Range
    Low 4.7900
    High 22.4900
  • Volume
    79,389
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 5.85
TimeVolumeANVS
09:32 ET164865.62
09:34 ET14995.765
09:36 ET14795.77
09:38 ET16885.815
09:43 ET3445.87
09:50 ET1005.815
09:52 ET10005.815
09:54 ET28585.8509
09:59 ET3005.76
10:03 ET6005.75
10:06 ET3005.77
10:10 ET20535.84
10:14 ET3145.74
10:15 ET8005.73
10:17 ET17355.74
10:19 ET10005.74
10:28 ET42995.7334
10:33 ET32475.7
10:37 ET6725.7092
10:39 ET25935.65
10:42 ET3505.67
10:44 ET7005.716
10:46 ET2005.6668
10:51 ET120505.66
10:55 ET14735.6399
11:04 ET10005.636
11:06 ET1005.6281
11:08 ET5125.65
11:11 ET1005.63
11:15 ET5815.6395
11:18 ET2385.63
11:20 ET1715.67
11:24 ET2005.62
11:40 ET6005.63
11:42 ET5005.6646
11:44 ET4005.68
11:45 ET5005.6301
11:47 ET13295.63
11:54 ET8355.64
11:56 ET2005.65
12:21 ET10005.73
12:25 ET2505.7001
12:27 ET11105.75
12:30 ET11975.76
12:56 ET1605.79
12:57 ET3495.81
12:59 ET7615.81
01:08 ET3025.83
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesANVS
Annovis Bio Inc
65.4M
-1.2x
---
United StatesANTX
AN2 Therapeutics Inc
64.7M
-0.8x
---
United StatesPASG
Passage Bio Inc
64.7M
-0.7x
---
United StatesTPST
Tempest Therapeutics Inc
64.4M
-1.6x
---
United StatesAVRO
AVROBIO Inc
64.2M
2.1x
---
United StatesRLYB
Rallybio Corp
64.0M
-0.8x
---
As of 2024-06-17

Company Information

Annovis Bio, Inc. is a clinical-stage drug platform company addressing neurodegeneration such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and other chronic neurodegenerative diseases. The Company is developing its lead product candidate, Buntanetap, which is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Buntanetap is a synthetically produced small molecule, orally administered, brain penetrant compound. Its product candidate ANVS405 is an intravenous drug being developed for acute indications and focused on protecting the brain after traumatic brain injury (TBI) and/or stroke. ANVS405 is the same compound as Buntanetap, given in cases of acute head and brain trauma. ANVS301 is an orally administered drug being developed to increase cognitive capability in later stages of AD and dementia. ANVS301 is observed to improve memory and learning in very old rats by lowering the number of errors from six to three.

Contact Information

Headquarters
101 LINDENWOOD DRIVE, SUITE 225MALVERN, PA, United States 19355
Phone
484-875-3192
Fax
610-727-4001

Executives

Independent Chairman of the Board
Michael Hoffman
President, Chief Executive Officer, Founder, Interim Principal Financial Officer, Director
Maria Maccecchini
Independent Director
Claudine Bruck
Independent Director
Reid Mccarthy
Independent Director
Mark White

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$65.4M
Revenue (TTM)
$0.00
Shares Outstanding
11.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.75
EPS
$-5.04
Book Value
$-0.74
P/E Ratio
-1.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.